资讯

US FDA Grants Orphan Drug Status To Sanofi’s GPRC5D-Targeting Monoclonal Antibody For ...
FDA granted Orphan Drug Designation to Sanofi’s SAR446523, a monoclonal antibody targeting GPRC5D, for relapsed/refractory ...